Asosiy kontentga oʻtish
Maqola

Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment

Yasuteru SakuraiTexas Biomedical Research Institute, San Antonio, TX, USAAndrey A. KolokoltsovThe University of Texas Medical Branch, Galveston, TX, USACheng‐Chang ChenLudwig-Maximilians-Universität MünchenMichael TidwellSouthwest Research Institute, San Antonio, TX, USAWilliam E. BautaSouthwest Research Institute, San Antonio, TX, USANorbert KlugbauerInstitute for Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs-Universität Freiburg, Freiburg, GermanyChristian GrimmCenter for Integrated Protein Science Munich (CIPSM) at the Department of Pharmacy–Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, GermanyChristian Wahl‐SchottLudwig-Maximilians-Universität MünchenMartin BielLudwig-Maximilians-Universität MünchenRobert A. DaveyTexas Biomedical Research Institute, San Antonio, TX, USA
2015en
ABI

Annotatsiya

Ebola virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently approved therapy. Cells take up Ebola virus by macropinocytosis, followed by trafficking through endosomal vesicles. However, few factors controlling endosomal virus movement are known. Here we find that Ebola virus entry into host cells requires the endosomal calcium channels called two-pore channels (TPCs). Disrupting TPC function by gene knockout, small interfering RNAs, or small-molecule inhibitors halted virus trafficking and prevented infection. Tetrandrine, the most potent small molecule that we tested, inhibited infection of human macrophages, the primary target of Ebola virus in vivo, and also showed therapeutic efficacy in mice. Therefore, TPC proteins play a key role in Ebola virus infection and may be effective targets for antiviral therapy.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba